ERNA - CIK 0000748592
The table below shows Eterna Therapeutics Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | $1.73M | $7.58M | $11.45M | - | $777.00K |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | $684.00K | $116.00K |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.13M |
| $2.35M |
| $9.60M |
| $13.68M |
| $18.77M |
| $1.72M |
| Property, plant & equipment | $94.00K | $85.00K | $493.00K | $236.00K | $670.00K | $502.00K |
| Goodwill | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $696.00K |
| Total assets | $5.83M | $5.27M | $49.13M | $22.28M | $32.43M | $3.75M |
| Accounts payable | $1.13M | $1.72M | $1.07M | $1.62M | $1.75M | $270.00K |
| Total current liabilities | $3.11M | $2.94M | $6.57M | $7.65M | $3.68M | $2.36M |
| Long-term debt | - | - | - | - | - | $532.00K |
| Total liabilities | $3.43M | $3.57M | $46.90M | $10.17M | $6.02M | $2.89M |
| Retained earnings | -$245.64M | -$231.54M | -$186.98M | -$165.30M | -$140.70M | -$135.89M |
| Total equity | $2.40M | $1.70M | $2.23M | $12.11M | $25.50M | $851.00K |